Literature DB >> 17222255

Organizing pneumonia and lymphoplasmacytic inflammation predict treatment response in idiopathic pulmonary fibrosis.

H R Collard1, C D Cool, K O Leslie, D Curran-Everett, S Groshong, K K Brown.   

Abstract

AIMS: To identify individual histopathological features within usual interstitial pneumonia pattern that predict responsiveness to immunosuppressive therapy. METHODS AND
RESULTS: Fifty-six retrospectively confirmed usual interstitial pneumonia pattern surgical lung biopsy specimens from subjects with idiopathic pulmonary fibrosis treated with corticosteroid and cytotoxic therapy were included. Eleven prospectively defined histopathological features were evaluated by two expert pulmonary pathologists. Regression analysis identified predictors of response to therapy, as defined by the change in percent predicted forced vital capacity over 6 months. Additional end-points were change in dyspnoea score over 6 months, and survival time. Improvement in percent predicted forced vital capacity was associated with lymphoplasmacytic inflammation, while worsening of percent predicted forced vital capacity was associated with the presence of organizing pneumonia and fibroblast foci. Worsening dyspnoea was associated with fibroblast foci. Survival time was associated with age and baseline percent predicted forced vital capacity, but not with any individual histopathological feature.
CONCLUSIONS: In pathological usual interstitial pneumonia pattern, the presence of lymphoplasmacytic inflammation predicts responsiveness to immunomodulatory therapy, while airspace organization predicts lack of response.

Entities:  

Mesh:

Year:  2007        PMID: 17222255     DOI: 10.1111/j.1365-2559.2006.02554.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Significance of bronchiolocentric fibrosis in patients with histopathological usual interstitial pneumonia.

Authors:  Kiminobu Tanizawa; Brett Ley; Eric Vittinghoff; Brett M Elicker; Travis S Henry; Paul J Wolters; Robert Brownell; Shuo Liu; Harold R Collard; Kirk D Jones
Journal:  Histopathology       Date:  2019-04-25       Impact factor: 5.087

2.  Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis.

Authors:  Seung-Ick Cha; Christine S Chang; Eun Kyung Kim; Jae W Lee; Michael A Matthay; Jeffrey A Golden; Brett M Elicker; Kirk Jones; Harold R Collard; Paul J Wolters
Journal:  Histopathology       Date:  2012-03-06       Impact factor: 5.087

3.  Rheumatoid lung disease.

Authors:  Kevin K Brown
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

Review 4.  The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.

Authors:  Fernando J Martinez; Alison Chisholm; Harold R Collard; Kevin R Flaherty; Jeffrey Myers; Ganesh Raghu; Simon L F Walsh; Eric S White; Luca Richeldi
Journal:  Lancet Respir Med       Date:  2016-12-06       Impact factor: 30.700

5.  Medical Research Council dyspnea scale does not relate to fibroblast foci profusion in IPF.

Authors:  Christina Triantafillidou; Effrosyni D Manali; Christina Magkou; Christina Sotiropoulou; Likurgos F Kolilekas; Konstantinos Kagouridis; Dimitra Rontogianni; Spyros A Papiris
Journal:  Diagn Pathol       Date:  2011-04-05       Impact factor: 2.644

6.  Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis.

Authors:  Elisabetta Balestro; Fiorella Calabrese; Graziella Turato; Francesca Lunardi; Erica Bazzan; Giuseppe Marulli; Davide Biondini; Emanuela Rossi; Alessandro Sanduzzi; Federico Rea; Chiara Rigobello; Dario Gregori; Simonetta Baraldo; Paolo Spagnolo; Manuel G Cosio; Marina Saetta
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.